Does how you get vancomycin affect your kidneys?
NCT ID NCT05823116
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at hospitalized adults who needed the antibiotic vancomycin. Participants were randomly assigned to receive it as a continuous drip or as intermittent doses. Researchers measured kidney function and injury markers to see if one method is gentler on the kidneys.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vancomycin
- What this could lead to
- If it works, this could help doctors choose the safer way to give vancomycin to protect patients' kidneys.
- What could go wrong
- This is a small, completed study with only 37 participants, so results may not apply to everyone. It looks at kidney markers, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VANCOMYCIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kentucky
Lexington, Kentucky, 40506, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists hunt for hidden clues to drug reactions in the blood
- New rapid blood test could slash unnecessary antibiotic use in sepsis
- Could a tailored antibiotic dose save more kids in the ICU?
- Are sick kids getting the right antibiotic dose? study aims to find out
- Can we get antibiotics right for kids on ECMO?
- New study aims to cut unnecessary antibiotics in fragile newborns